Latest news with #healthtech
National Post
16 hours ago
- Business
- National Post
iFIT Expands Global Reach with Rollout of AI Coach in 19 Countries
Article content PARK CITY, Utah — iFIT Inc., a global leader in connected fitness and interactive content, today announced the expansion of its iFIT AI Coach (beta) across 19 countries: Australia, Austria, Belgium, Canada, Finland, France, Germany, Ireland, Italy, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, and the UK. This strategic expansion brings iFIT's intelligent, personalized fitness technology to more athletes around the globe. Article content Article content AI Coach is iFIT's most advanced digital training tool to date, leveraging proprietary technology and user data to deliver hyper-personalized fitness and wellness plans. The tool adapts dynamically to users' goals, schedules, and performance, offering real-time feedback and motivation across a wide range of fitness categories—from strength and cardio to recovery and mindfulness. Article content 'Expanding iFIT AI Coach beyond the U.S. reflects our mission to make intelligent, interactive fitness more accessible around the globe,' said Bart Mueller, Chief International Officer. 'This rollout empowers more users to take control of their health with support that's customized, convenient, and rooted in world-class technology.' Article content iFIT AI Coach uses machine learning to continuously refine recommendations based on progress, preferences, and performance. The expansion is designed to meet growing global demand for digital-first, flexible fitness solutions that deliver results at home, at the gym, or on the go. Article content The AI Coach chat experience will be available through the iFIT mobile app. Workouts recommended by AI Coach will also appear on screen on select NordicTrack and ProForm equipment, with language support tailored to each region. Article content About iFIT Inc. iFIT Inc. is a global leader in fitness technology, pioneering connected fitness to help people live longer, healthier lives. With a community of more than 6 million athletes around the world, iFIT delivers immersive, personalized workout experiences at-home, on the go, and in the gym. Powered by a comprehensive ecosystem of proprietary software, innovative hardware, and engaging content, the iFIT platform brings fitness to life through its portfolio of brands: NordicTrack, ProForm, Freemotion, and the iFIT app. From cardio and strength training to recovery, iFIT empowers athletes at every stage of their fitness journey. For more information, visit Article content Article content Article content Article content Article content
Yahoo
21 hours ago
- Business
- Yahoo
FeNO Breathing Monitors Market Global Forecast to 2030, Featuring Bedfont Scientific, Bosch Healthcare Solutions, CAIRE, COSMED, e-LinkCare Meditech, ECO MEDICS, MGC Diagnostics, NIOX and Vitalograph
Key market opportunities for FeNO breathing monitors include the integration with telehealth and homecare models, driven by technological advancements and reduced device costs. With rising demand for personalized respiratory care, leveraging sensor innovations and aligning with clinical guidelines will be essential to capturing growth in this evolving market. FeNO Breathing Monitors Market Dublin, June 02, 2025 (GLOBE NEWSWIRE) -- The "FeNO Breathing Monitors Market by Technology, Patient Age Group, Warning Signal, Distribution Channel, Application, End User - Global Forecast to 2030" has been added to offering. The FeNO Breathing Monitors Market has demonstrated substantial growth, with its size expanding from USD 275.95 million in 2024 to USD 303.10 million in 2025, and is projected to reach USD 490.87 million by 2030. As a critical tool in respiratory care, FeNO breathing monitors empower clinicians and patients by providing precise measurements of fractional exhaled nitric oxide, facilitating improved clinical decision-making and personalized therapy adjustments. The increasing adoption across various healthcare environments underscores the technology's transformative potential in managing chronic respiratory diseases. Key Technological and Clinical Transformations FeNO breathing monitors are experiencing rapid advancements due to innovations in sensor technology and clinical practice changes. Sensor chemistry and miniaturization progress have reduced costs and enhanced portability, supporting their integration into smartphone-linked platforms and remote monitoring systems. Such developments enhance the appeal of home-based care models and telehealth services, which are now playing a more significant role in respiratory disease management. Additionally, clinical guidelines recognizing exhaled nitric oxide as an essential biomarker for inflammation in asthma and respiratory conditions have propelled the demand for FeNO monitoring among healthcare providers. This demand is driven by improved patient outcomes and cost savings linked with routine monitoring, aiding in strategic planning and competitive advantage for organizations in this field. Evaluating the Strategic Consequences of 2025 US Sensor Tariffs The introduction of new tariffs on imported medical sensors in 2025 has introduced challenges within the FeNO monitor ecosystem. The increased duties on components like sensor substrates and proprietary reagent kits have required manufacturers to reassess their cost structures and sourcing strategies. Some industry players are exploring domestic supply sources, while others incorporate new revenue models to offset tariff-induced costs. This situation highlights the need for agility in procurement and manufacturing strategies to maintain competitive pricing and mitigate risks associated with evolving trade policies. Key Takeaways from This Report This report identifies the convergence of technological innovations and evolving clinical guidelines as critical growth drivers for FeNO breathing monitors. Stakeholders can leverage these advancements for strategic planning and improving competitive edge. The adaptive responses to tariff challenges also illustrate the importance of agile procurement strategies in maintaining market positioning. Extensive segmentation analysis across technology, patient demographics, distribution channels, and application provides nuanced insights, enabling identification of market entry strategies and opportunities for growth. Nuanced Segmentation Insights Market segmentation reveals distinct characteristics among technology types, patient demographics, and application domains. Chemiluminescence sensors remain favored in research and hospital settings for their high sensitivity, while electrochemical sensors dominate homecare for their cost efficiency. Pediatric devices must accommodate gentle interfaces and intuitive designs to ensure reliable usage. Moreover, distribution strategies vary between offline channels with established supply chains and online channels that enhance direct consumer engagement. A thorough understanding of these segments allows for customization of value propositions to resonate with targeted user groups. Regional Dynamics Adoption of FeNO monitors varies by region, with the Americas benefiting from robust reimbursement frameworks and high asthma prevalence that promote device utilization. In Europe, Middle East & Africa, adoption ranges from well-established in Western countries to emerging uptake in Eastern and Middle Eastern regions. Asia-Pacific's demand is driven by urbanization and increasing respiratory diseases, necessitating tailored market entry strategies that consider regional regulatory environments and partnership networks. Competitive Landscape and Strategic Moves The competitive landscape for FeNO breathing monitors sees established corporations leveraging device-to-cloud integrations to solidify market positions, while newcomers emphasize affordability and usability. Strategic moves include partnerships with electronic health record vendors and acquiring technology startups to bolster service offerings. Aligning products with customer pain points is essential for achieving competitive advantage and market leadership. Conclusion FeNO breathing monitors are at the forefront of respiratory care innovation, enhancing the measurement of airway inflammation and integrating deeply into clinical practice. As the market evolves, stakeholders must navigate technological advances, regulatory changes, and global trade dynamics to capitalize on growth opportunities. Implementing agile sourcing strategies, fostering key opinion leader partnerships, and prioritizing interoperability within digital health ecosystems are critical for maintaining leadership in this rapidly developing field. Key Attributes: Report Attribute Details No. of Pages 189 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $303.1 Million Forecasted Market Value (USD) by 2030 $490.87 Million Compound Annual Growth Rate 10.0% Regions Covered Global Key Topics Covered: 1. Preface2. Research Methodology3. Executive Summary4. Market Overview5. Market Dynamics5.1. Rising demand for portable and user-friendly FeNO breath analysis devices5.2. Expansion of FeNO breath monitors into emerging markets and remote areas5.3. Role of AI and machine learning in improving FeNO device diagnostics5.4. Trends in insurance reimbursement policies supporting FeNO device usage5.5. Advancements in FeNO technology enhancing asthma management accuracy and ease5.6. Influence of regulatory approvals accelerating FeNO device market expansion5.7. Impact of telehealth integration on the adoption of FeNO breathing monitors5.8. Growth of personalized treatment plans driven by FeNO monitoring data5.9. Increasing awareness about respiratory health boosting FeNO monitor sales5.10. Collaborations between healthcare providers and tech firms for FeNO innovation6. Market Insights6.1. Porter's Five Forces Analysis6.2. PESTLE Analysis7. Cumulative Impact of United States Tariffs 20257.1. Comprehensive overview of major United States tariffs affecting the FeNO Breathing Monitor market from 2023 to 20257.2. Historical analysis and underlying economic rationale behind United States tariff policies affecting developed and developing countries from 2018 to 20257.3. Detailed analysis of the direct inflationary effects triggered by recent United States tariff implementations on the global economy7.4. Examination of reciprocal tariff dynamics and resultant trade wars between the United States and major global trading regions within a broader geopolitical framework7.5. Evaluation of the immediate and long-term economic and political impacts of United States tariffs on key international trading partners7.6. Identification of structural transformations in the United States economy driven by tariff-induced supply chain shifts and altered consumer purchasing behaviors7.7. Proposed policy measures and strategic approaches to alleviate the negative impacts of tariffs on the United States and its global trading partners8. FeNO Breathing Monitors Market, by Technology8.1. Introduction8.2. Chemiluminescence Sensors8.3. Electrochemical Sensors9. FeNO Breathing Monitors Market, by Patient Age Group9.1. Introduction9.2. Adults9.3. Geriatrics9.4. Pediatrics9.4.1. Infant9.4.2. Toddler10. FeNO Breathing Monitors Market, by Warning Signal10.1. Introduction10.2. Beep10.3. Light11. FeNO Breathing Monitors Market, by Distribution Channel11.1. Introduction11.2. Offline11.3. Online11.3.1. Brand Websites11.3.2. eCommerce Platforms12. FeNO Breathing Monitors Market, by Application12.1. Introduction12.2. Allergic Rhinitis12.3. Asthma Management12.3.1. Acute Asthma12.3.2. Chronic Asthma12.4. Chronic Obstructive Pulmonary Disease (COPD)12.5. Respiratory Distress Monitoring13. FeNO Breathing Monitors Market, by End User13.1. Introduction13.2. Ambulatory Care Settings13.3. Homecare Settings13.4. Hospitals & Clinics13.5. Research Laboratories14. Americas FeNO Breathing Monitors Market15. Europe, Middle East & Africa FeNO Breathing Monitors Market16. Asia-Pacific FeNO Breathing Monitors Market17. Competitive Landscape17.1. Market Share Analysis, 202417.2. FPNV Positioning Matrix, 202417.3. Competitive Analysis Bedfont Scientific Ltd. Bosch Healthcare Solutions GmbH CAIRE Inc. COSMED srl e-LinkCare Meditech Co.,Ltd. ECO MEDICS AG MGC Diagnostics Corporation NIOX Group plc Vitalograph Ltd. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment FeNO Breathing Monitors Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Washington Post
2 days ago
- Business
- Washington Post
‘Femtech' takes on the women's health-care marketplace
Could you use some discreet help with birth control from a $14.99-a-month period-tracking app? How about a hands-free, wearable breast pump, for $549; a $299 wristband to soothe hot flashes; or an extra-slim, temperature-neutral, LED-lit speculum to bring to gynecologists' appointments — part of a $125 kit including 'comfy socks'? These products and more are part of a fast-growing industry known as 'femtech' — high-tech solutions for women's health needs — whose many female founders say they're tackling age-old inequities.
Phone Arena
2 days ago
- Business
- Phone Arena
Discounted by $261, the Galaxy Watch Ultra is just too good to pass up
If you've been thinking about getting the Galaxy Watch Ultra, now is the perfect time to grab one. A third-party seller on Amazon is offering an incredible $261 discount, letting you get one of the best smartwatches on the market for just under $390. Even though the offer isn't coming directly from Amazon, you still get a 30-day return window, so you can buy with confidence, knowing you have the option to return the device if needed. $261 off (40%) Score the Galaxy Watch Ultra at a $261 discount on Amazon! This tough smartwatch is built for anything, boasting standout features like FDA-approved sleep apnea detection and Samsung's advanced body composition tracking. Don't wait—save while you can! Buy at Amazon Of course, price matters, but what really makes this Samsung watch worth considering is its durability and premium design. It features a rugged titanium case and a sapphire crystal display, making it tough enough for everyday wear and even more extreme conditions. With IP68 and 10ATM ratings, it handles dust with ease, withstands up to 30 minutes in five feet of water, and even holds up during brief dives as deep as 328 feet. Beyond its tough build, it also delivers great battery life. You can get up to two days per charge with heart rate tracking enabled and the always-on display turned off. Plus, it's packed with advanced health features, including FDA-approved sleep apnea detection and Samsung's body composition functionality. All things considered, the Galaxy Watch Ultra is the complete package, offering durability, a plethora of features, and solid battery life. Furthermore, it's a true bargain at its current price on Amazon. And while this $261 discount comes and goes, it creates an unmissable opportunity to up your smartwatch game every time. So, don't miss out! Tap the offer button at the beginning of this article and score one at a bargain price today!
Khaleej Times
3 days ago
- Business
- Khaleej Times
PricelessMed and International Modern Hospital sign strategic partnership to expand value healthcare access in Dubai
PricelessMed, the UAE's first health tech platform focused exclusively on discounted medical services, proudly announces the signing of a strategic partnership with International Modern Hospital (IMH). The signing ceremony took place at IMH on May 20, 2025, marking a significant milestone in both institutions' shared vision of making high-quality healthcare more accessible and affordable across the region. The ceremony brought together leaders from both organisations, including PricelessMed's managing director, PricelessMed business development team, and PricelessMed legal advisors, alongside International Modern Hospital's chief executive officer, medical director, and director operations. The agreement reinforces PricelessMed's commitment to growing its provider network with top-tier medical institutions and highlights IMH's continued legacy of excellence in serving the UAE community. A Hospital with Legacy and Capacity Founded in 2005, International Modern Hospital is a well-established private healthcare provider that has earned the trust of Dubai's growing population over two decades. Strategically located near the Dubai-Sharjah border, International Modern Hospital is ideally positioned to serve patients from both emirates. The hospital features a robust infrastructure with; a 100+ bed capacity supporting inpatient services. With state-of-the-art operating rooms for surgeries and critical interventions. A fully operational Emergency Department (ER) providing 24/7 care. International Modern Hospital is known for combining international clinical standards with compassionate, community-centered care, making it a natural partner for PricelessMed's mission. A New Chapter in Accessible Healthcare Basma Fouda, PricelessMed MD highlighted that this partnership would bring a selection of high-demand medical services from International Modern Hospital onto the PricelessMed platform, allowing users to access; Specialty medicine across disciplines such as internal medicine, pediatrics, OB-GYN, and more. Advanced laboratory diagnostics for routine and specialized testing. Comprehensive radiology services including X-rays, ultrasound, CT scans, and MRI. By listing these services on PricelessMed's user-friendly mobile app and website, patients will now have access to transparent discounts, real-time availability, and simple booking with one of Dubai's most trusted hospitals. Strategically Aligned for Mutual Growth "The collaboration between International Modern Hospital and PricelessMed is more than a service listing; it represents a strategic alignment between two organisations committed to innovation, community health, and operational excellence," said Kishan Pakkal, CEO of International Modern Hospital. 'Partnering with PricelessMed opens a valuable new channel for International Modern Hospital to connect with self-paying patients who are looking for premium healthcare at accessible prices,' he said. 'This collaboration supports our broader vision of serving a larger population and reinforces our role as a pioneering healthcare provider in both Dubai and Sharjah. Our strategic location at the intersection of both emirates uniquely positions us to reach diverse communities, and with PricelessMed's digital platform and marketing support, we can further highlight our specialised services, departments, and expert consultants to those who need them most.' For PricelessMed, onboarding International Modern Hospital expands its network with a reputable hospital partner that enhances the platform's credibility and strengthens its presence in Dubai and Sharjah. International Modern Hospital's range of services and high standards align seamlessly with PricelessMed's focus on quality, accessibility, and value. A Partnership Built on Shared Vision Speaking on the occasion, Basma Fouda from PricelessMed commented: 'We are thrilled to welcome International Modern Hospital to our growing list of partner providers. Their legacy of excellence, comprehensive care, and prime location makes them a perfect fit for our platform. Together, we will empower more patients to access the care they need, without financial strain.' International Modern Hospital, Director Operations, Remya Venugopalan, added: 'Partnering with PricelessMed enables us to further our mission of delivering high-quality healthcare to all segments of society. As the healthcare landscape evolves, this collaboration positions International Modern Hospital to be at the forefront of digital access and affordability.' 'This partnership represents more than just a business agreement, it reflects a shared commitment to ethical, transparent, and patient-centered healthcare,' said Ahmed Al Adly, Founder of Al Adly and Co Legal Firm and PricelessMed Legal Advisor. 'From a legal and compliance perspective, we have ensured that this collaboration upholds the highest standards of data protection, operational integrity, and regulatory alignment. We are proud to formalize this relationship with a trusted institution like International Modern Hospital, and we view it as a strategic alliance built on trust, shared values, and long-term impact for the community.' Unlocking Affordable, High-Quality Healthcare. PricelessMed, launched in May 2025 by Priceless Health LLC-FZ, is the first dedicated health tech platform in the UAE offering discounts of 15 per cent to 70 per cent on over 1,000 medical services. Designed with a seamless user experience, the platform connects users with verified providers across specialties like pediatrics, fertility, traditional medicine, aesthetics, dental care, and more. The partnership with Legal Firm adds to a rapidly expanding list of providers offering services across clinics, hospitals, day surgery units, and home care facilities. Through a robust search engine, advanced filtering options, and transparent pricing, PricelessMed delivers a seamless and digital healthcare experience. With subscriptions currently free until October 2025, users are encouraged to explore the app and experience first-hand how PricelessMed is making healthcare more accessible than ever before.
